in intermediate-stage HCC, a real cure for HCC may cease to be a dream. In fact, clinical trials of combination therapy with lenvatinib and pembrolizumab for HCC have already started (Fig.
No takes yet. Share an insight, caveat, or question.
Masatoshi Kudo (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: